Hoyoung Huh

CIK 1401267 · Chairman, Scientific Adv. Bd. · last filed 2025-12-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$64.93M

Companies

7

Total Filings

54

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AKTX Director 4,805,311 $13.40 $64.39M $0 3 2025-12-18
PLRX Director 239,619 $1.13 $270.8K $0 6 2025-06-09
Eidos Therapeutics, Inc. (EIDX) Delisted Director $0 1 2018-06-22
CTMX Director $3.01 $0 3 2018-06-15
GERN Director 154,301 $1.15 $177.4K $0 19 2018-05-17
FACT Director 8,333 $10.65 $88.7K $0 1 2009-09-09
NKTR Chief Operating Officer $59.38 $0 6 2008-12-04

Recent Filings · Page 3 of 6

54 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-30 PLRX Grant (A) $0 EDGAR
2020-06-09 PLRX Conv (C) +139,860 $0 EDGAR
2018-06-22 Eidos Therapeutics, Inc. (EIDX) Delisted Grant (A) $0 EDGAR
2018-06-15 CTMX Grant (A) $0 EDGAR
2018-05-17 GERN Grant (A) $0 EDGAR
2018-01-02 GERN Grant (A) +10,764 $0 EDGAR
2017-10-02 GERN Grant (A) +8,888 $0 EDGAR
2017-06-30 GERN Grant (A) +6,995 $0 EDGAR
2017-06-22 CTMX Grant (A) $0 EDGAR
2017-05-10 GERN Grant (A) $0 EDGAR
Showing 2130 of 54
Page 3 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.